AAISG 2023 Annual Meeting
The Allergy, Asthma & Immunology Society of Georgia presents their Annual Meeting for Allergists and Immunologists to learn new techniques and treatments in order to provide better patient care using the safest, most proven therapies presented by leaders in their field. AAISG also seeks to provide best practices in practice management to aid in the care of patients. This year's meeting will cover topics such as food allergy, chronic sinusitis, long COVID, pruritus and more.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American College of Allergy, Asthma & Immunology (ACAAI) and the Allergy, Asthma & Immunology Society of George (AAISG). The American College of Allergy, Asthma and Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Practicing allergists, pulmonologists and allied healthcare professionals in the field of allergy, asthma and immunology.
At the conclusion of this activity learners should be able to:
1. Identify patients where genetic testing is indicated.
2. Interpret the results of genetic testing.
3. Choose the appropriate biologic therapy for allergic and immunologic diseases.
4. Manage the patient who has previously recovered from COVID infection.
2023 AAISG Meeting Agenda
Friday, May 5, 2023 Event Location
6:00 pm – 7:00 pm Cocktails and Registration (non-CME) Cypress Cove
7:00 pm – 8:00 pm Betty Wray Lecture and Dinner
Inappropriate Food Allergy IgE Testing | Gerald Lee, MD Cypress Cove
8:00 pm – 9:00 pm Social Networking Time (non-CME) Cypress Cove
Saturday, May 6, 2023 Event Location
7:00 am – 8:00 am Breakfast (Non-CME) Loblolly Hall
8:00 am – 9:00 am Cutaneous Mastocytosis | Leslie Lawley, MD Longleaf A/B
9:00 am – 10:00 am When It’s Not Atopic Dermatitis | Leslie Lawley, MD Longleaf A/B
10:00 am – 10:20 am Break (non-CME)
10:20 am – 10:40 am Pruritus | Christina Smith, MD Longleaf A/B
10:40 am – 11:00 am When the Treatment Is Worse Than the Ailment: A Case of Anaphylaxis Triggered by Methylpredinsolone | Mandy Hall, MD Longleaf A/B
11:00 am – 12:00 pm Update on Practice Management | Mohamed Yassin, MD Longleaf A/B
12:00 pm – 12:30 pm Brief Overview from ACAAI | Kathleen May, MD (non-CME) Longleaf A/B
12:30 pm – 1:00 pm Business Meeting (All members encouraged to attend) (non-CME) Longleaf A/B
12:00 pm – 1:30 pm Lunch (non-CME) Loblolly Hall
7:30 pm – 10:00 pm Dinner and Entertainment (non-CME) Callaway Discover Center
Sunday, May 7, 2023 Event Location
7:00 am – 8:00 am Breakfast (non-CME) Loblolly Hall
8:00 am – 9:00 am Update on Chronic Sinusitis | Tom Higgins, MD Longleaf A/B
9:00 am – 9:20 am Specific Antibody Deficiency |Jennifer Xu, MD Longleaf A/B
9:20 am – 9:40 am Eczema Action Plan Implementation: A Quality Improvement Project | Sofia Edwards Salmon, MD Longleaf A/B
9:40 am – 10:00 am Break (non-CME)
10:00 am – 11:00 am Long COVID | Alex Truong, MD Longleaf A/B
11:00 am – 11:30 am Lunch (non-CME) Loblolly Hall
11:30 am – 12:30 pm CSU Trivia | Merin Kalangara, MD (non-CME Presentation) Longleaf A/B
Disclosure Policy and Disclosures
As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewer, and other individuals in a position to control or influence the content of an activity must disclose all financial relationships with any ineligible company that have occurred within the past 24 months.
Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients. (Examples of ineligible companies include: Advertising, marketing, or communication firms whose clients are ineligible companies; bio-medical startups that have begun a governmental regulatory approval process; compounding pharmacies that manufacture proprietary compounds; device manufacturers or distributors; diagnostic labs that sell proprietary products; growers, distributors, manufacturers or sellers of medical foods and dietary supplements; manufacturers of health-related wearable products; pharmaceutical companies or distributors; pharmacy benefit managers; reagent manufacturers or sellers).
The ACCME does not consider providers of clinical service directly to patients to be commercial interests. For more information, visit www.accme.org. All identified relevant relationships must be mitigated and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure of or absence of relevant financial relationships be provided to the learners prior to the start of the activity.
Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials.
Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI.
All relevant financial relationships with ineligible companies have been mitigated.
The individuals listed below disclose the following financial relationships:
Leslie Lawley, MD, Speaker
Thomas Higgins, MD, Speaker
Researcher: GlaxoSmithKline, Optinose, Medtronic, Biohaven (Pfizer)
Speaker: Pfizer, Inc
Advisor: Sanofi/Regeneron, Merck, Medtronic, Optinose
The following have no relevant financial relationships to disclose:
Gerald Lee, MD, Program Chair, Speaker
Julie Ellerbee, Planner
Jennifer Shih, Planner
Sofia Edwards-Salmon, MD, Speaker
Amanda Hall, MD, Speaker
R. Christina Smith, MD, Speaker
Alex Truong, MD, Speaker
Jennifer Xu, MD, Speaker
Mohamed Yassin, MD, Speaker
- 7.50 AMA PRA Category 1 Credit™
- 7.50 Attendance